SCTL 0.00 Stock Price Societal CDMO, Inc.
Range: | 0.26-1.28 | Vol Avg: | 998391 | Last Div: | 0 | Changes: | 0.01 |
Beta: | 1.58 | Cap: | 0.12B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Fri Mar 07 2014 | Empoloyees: | 258 |
CUSIP: | 75629F109 | CIK: | 0001588972 | ISIN: | US75629F1093 | Country: | US |
CEO: | Mr. J. David Enloe Jr. | Website: | https://www.societalcdmo.com |
Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.